Novoprotein(SH:688137) Zheng Quan Zhi Xing·2025-09-04 16:06Core Viewpoint - The company is convening its first extraordinary general meeting of shareholders in 2025 to discuss key proposals, including the use of excess raised funds to supplement working capital and the reappointment of an accounting firm for financial auditing [6][8]. Group 1: Meeting Procedures - The meeting will follow a structured agenda, allowing shareholders to exercise their rights, including speaking, questioning, and voting [2][3]. - Shareholders must register and present necessary identification documents to participate in the meeting [1][2]. - Voting will be conducted through both on-site and online methods, with specific time frames for each [4][6]. Group 2: Proposals - Proposal 1 involves using CNY 72 million (approximately USD 10.1 million) of excess raised funds to permanently supplement working capital, which represents 29.73% of the total excess funds raised of CNY 242.2 million (approximately USD 34.1 million) [6][8]. - Proposal 2 seeks to reappoint Rongcheng Accounting Firm for the 2025 financial audit, with an audit fee of CNY 700,000 (approximately USD 98,000), maintaining the same fee as the previous year [8][12].